【レポートの概要（一部）】
1. Report Overview
1.1. The Prostate Cancer Therapeutics Market Overview
1.2. Prostate Cancer Therapeutics Market Segmentation
1.3. Why You Should Read This Report
1.4. How This Report Delivers
1.5. Key Questions Answered by This Analytical Report
1.6. Who is This Report For?
1.7. Methodology
1.8. Frequently Asked Questions (FAQ)
1.9. Associated Reports
1.10. About Visiongain
2. Introduction to Prostate Cancer
2.1. What Is Cancer?
2.2. Phenotypic Characteristics of Cancer Cells
2.2.1. Uncontrolled Growth
2.2.2. Loss of Functioning Apoptotic Pathways
2.2.3. Lack of Differentiation
2.2.4. Increased Angiogenesis
2.2.5. Potential for Metastasis
2.2.6. Genetic Instability
2.3. What Causes Cancer?
2.3.1. Worldwide Prevalence of Cancer: A Global Picture
2.4. What is Prostate Cancer?
2.4.1. Worldwide Prevalence of Prostate Cancer: Rapid Global Growth
2.4.2. Risk Factors for Prostate Cancer
2.5. How is Prostate Cancer Diagnosed?
2.5.1. PSA Testing
2.5.2. Digital Rectal Examination Testing
2.5.3. Prostate Cancer Screening: Does the Cost Justify the Means?
2.5.4. Alternative Tests Could Change Diagnostics
2.6. Treating Prostate Cancer
2.6.1. Localised Prostate Cancer: Surgery/Radiation is Most Preferred
2.6.1.1. Brachytherapy
2.6.1.2. Radical Prostatectomy
2.6.1.3. External Beam Radiation Therapy
2.6.1.4. Cryotherapy
2.6.1.5. High-Intensity Focused Ultrasound (HIFU)
2.6.2. Advanced Local or Metastatic Prostate Cancer: Androgen Deprivation Therapy
2.6.3. Non-Metastatic CRPC: Ketoconazole and Anti-Androgens
2.6.4. Metastatic CRPC: Expanding the Standard Taxotere Treatment Paradigm
2.6.5. First Line Chemotherapy: Docetaxel is a Standard Treatment
2.6.6. Post Docetaxel Therapy: Five FDA Approved Drugs
2.6.7. Second Line Chemotherapy: Jevtana Approved in 2010
3. The Prostate Cancer Therapeutics Market 2016-2026
3.1. The Global Prostate Cancer Therapeutics Market, 2014
3.2. The Global Prostate Cancer Therapeutics Market Forecast, 2016-2026
3.3. The Global Prostate Cancer Therapeutics Market: Drivers and Restraints, 2016-2026
4. The Prostate Cancer Drugs Market 2016-2026
4.1. The Prostate Cancer Drugs Market: Greater Choice of Drugs Increasing Competition in the mCRPC Setting
4.2. The Prostate Cancer Drugs Market, 2015
4.3. Leading Prostate Cancer Drugs: Market Forecast, 2015-2025
4.4. Market Share of Leading Prostate Cancer Drugs, 2016-2026
4.5. First Generation Chemotherapies
4.5.1. Taxotere (Sanofi)s
4.5.1.1. Taxotere Sales, 2014
4.5.1.2. Taxotere Sales Forecast, 2016-2026
4.6. Second Generation Chemotherapies
4.6.1. Jevtana (Sanofi)
4.6.1.1. Jevtana Sales, 2014 & 2015
4.6.1.2. Jevtana Sales Forecast, 2016-2026
4.7. First Generation Hormones
4.7.1. Casodex (AstraZeneca)
4.7.1.1. Casodex Sales, 2014 & 2015
4.7.1.2. Casodex Sales Forecast, 2016-2026
4.7.2. Leuplin (Takeda) / Lupron (AbbVie)
4.7.2.1. Leuplin & Lupron Sales, 2014 & 2015
4.7.2.2. Leuplin & Lupron Sales Forecast, 2016-2026
4.7.3. Zoladex (AstraZeneca)
4.7.3.1. Zoladex Sales, 2014 & 2015
4.7.3.2. 2 Zoladex Sales Forecast, 2015-2025
4.8. Second Generation Hormones
4.8.1. Zytiga (Johnson & Johnson)
4.8.1.1. Zytiga Sales, 2014 & 2015
4.8.1.2. Zytiga Sales Forecast, 2016-2026
4.8.2. Xtandi (Medivation/ Astellas Pharma)
4.8.2.1. Xtandi Sales, 2014 & 2015
4.8.2.2. Xtandi Sales Forecast, 2016-2026
4.9. Radiopharmaceuticals
4.9.1. Xofigo (Bayer)
4.9.1.1. Xofigo Sales, 2014 & 2015
4.9.1.2. Xofigo Sales Forecast, 2016-2026
4.10. Other Drugs
4.11. Prostate Cancer Drugs Pipeline, 2016
4.11.1. Phase III Development
4.11.1.1. DCVax-Prostate (NorthWest Biotherapeutics)
4.11.1.2. Tookad Soluble (Steba Biotech)
4.11.1.3. ProstAtak (Advantagene)
4.11.1.4. ARN-509 (Johnson & Johnson)
4.11.1.5. Custirsen (Oncogenex)
4.11.1.6. Prostvac (Bavarian Nordic)
4.11.1.7. Galeterone (Tokai Pharmaceuticals)
4.11.2. Phase II development
4.11.2.1. GDC-0068 (Roche)
4.11.2.2. PSMA ADC (Progenics Pharmaceuticals)
4.11.2.3. Apatorsen (OGX-427 – OncoGenex Pharmaceuticals)
4.11.3. Phase I
4.11.3.1. RG7450 (Roche)
4.11.3.2. BAY2010112 (Bayer Pharmaceuticals)
4.11.3.3. BPX-201 (Bellicum Pharmaceuticals)
5. The Prostate Cancer Devices Market, 2016-2026
5.1. The Prostate Cancer Devices Market 2014
5.2. The Prostate Cancer Devices Market Forecast, 2016-2026
5.3. The Market Shares of Leading Prostate Cancer Devices Submarkets, 2016-2026
5.4. The Radical Prostatectomy Market 2016-2026
5.4.1. Intuitive Surgical’s da Vinci Surgical System
5.5. The External Beam Radiation Therapy Market, 2016-2026
5.6. The Brachytherapy Market 2016-2026
5.7. The Cryotherapy Market 2016-2026
5.8. The HIFU Market, 2016-2026
6. The Leading Companies in the Prostate Cancer Therapies Market, 2016
6.1. The Leading Companies in the Prostate Cancer Drugs Market, 2016
6.2. Johnson & Johnson (J&J)
6.2.1. Sales and Performance Analysis, 2015
6.2.2. Pharmaceutical Segment Sales Analysis, 2015
6.2.3. Oncology Drugs Sales and Performance Analysis, 2015
6.2.4. Pharmaceutical Segment R&D Performance Analysis, 2015
6.2.5. Acquisition of Aragon Pharmaceuticals
6.3. AstraZeneca
6.3.1. Sales and Performance Analysis, 2015
6.3.2. Pharmaceutical Segment Sales & R&D Analysis by Segment, 2015
6.3.3. Oncology Drugs Sales and Performance Analysis, 2015
6.4. Sanofi
6.4.1. Sales and Performance Analysis, 2015
6.4.2. Sales and Performance Analysis by Segment, 2015
6.4.3. Oncology Sales and Performance Analysis, 2015
6.4.4. R&D Performance Analysis, 2015
6.4.5. Oncology Pipeline Portfolio
6.5. AbbVie
6.5.1. Sales and Performance Analysis, 2015
6.5.2. R&D Performance Analysis, 2015
6.5.3. Humira: From “First-In-Class” to “Best-In-Class”, 2015
6.5.4. Oncology Portfolio Pipeline Products, 2015
6.6. Leading Companies in the Prostate Cancer Devices Market 2016-2026
6.7. Varian Medical Systems
6.7.1. Sales and Performance Analysis, 2015
6.7.2. Oncology Segment Sales Analysis, 2015
6.7.3. Sales Analysis by Region, 2015
6.7.4. R&D Performance Analysis, 2015
6.7.5. Key Oncology Products, 2015
6.7.6. Varian and Siemens Partnership: Shaping the Future of Cancer Care
6.8. Elekta
6.8.1. Sales and Performance Analysis, 2015
6.8.2. Sales and Performance Analysis by Region, 2015
6.8.3. Elekta and Philips Establish Research Consortium
6.8.4. Product Launch and Development, 2015
6.9. Theragenics Corporation (acquired by Juniper Acquisition Corporation)
6.9.1. Theragenics Sales Performance Analysis, 2014
6.9.2. Theragenics Sales Performance by Operation, 2012
6.9.3. Sales and Performance Analysis by Business Unit, 2012
6.9.4. Mergers and Acquisitions
6.9.4.1. Juniper’s acquisition of Theragenics
6.9.4.2. Acquisition of US & Canadian Seed Business of Eckert & Ziegler BEBIG
6.9.4.3. Acquisition of Needle Tech Products
6.9.4.4. Acquisition of Galt Medical
7. The Leading National Markets, 2016-2026
7.1. Regional Breakdown of the Prostate Cancer Therapeutics Market, 2014
7.2. The Prostate Cancer Therapeutics Market: Regional Forecast, 2016-2026
7.3. Market Shares Forecasts of Leading National Prostate Cancer Therapeutics Markets, 2016-2026
7.4. The US Prostate Cancer Therapeutics Market 2016-2026
7.5. The European Prostate Cancer Therapeutics Market, 2014
7.6. The European Prostate Cancer Therapeutics Market, 2015-2025
7.6.1. The German Prostate Cancer Therapeutics Market, 2016-2026
7.6.2. The French Prostate Cancer Therapeutics Market, 2016-2026
7.6.3. The UK Prostate Cancer Therapeutics Market, 2015-2025
7.6.4. The Spanish Prostate Cancer Therapeutics Market, 2016-2026
7.6.5. The Italian Prostate Cancer Therapeutics Market, 2016-2026
7.7. The Japanese Prostate Cancer Therapeutics Market, 2016-2026
7.8. The Chinese Prostate Cancer Therapeutics Market, 2016-2026
7.9. The Brazilian Prostate Cancer Therapeutics Market, 2016-2026
7.10. The Russian Prostate Cancer Therapeutics Market, 2016-2026
7.11. The Indian Prostate Cancer Therapeutics Market, 2016-2026
7.12. The South Korean Prostate Cancer Therapeutics Market, 2016-2026
7.13. The Rest of the World Prostate Cancer Therapeutics Market, 2016-2026
8. Qualitative Analysis of the Prostate Cancer Therapeutics Market 2016-2026
8.1. SWOT Analysis, 2016-2026
8.2. Strengths
8.2.1. Rapidly Ageing Male Populations Worldwide
8.2.2. A Number of Promising Pipeline Drug Candidates
8.2.3. Successful Partnerships Between Big and Small Pharmaceutical Companies Leading to New Products
8.3. Weaknesses
8.3.1. High Treatment Costs
8.3.2. High Levels of Phase III Attrition
8.4. Opportunities
8.4.1. Rising Incidence of Cancer
8.4.2. Development of Emerging Markets
8.5. Threats
8.5.1. Concerns about Efficacy and Toxicity of Drugs
8.5.2. Increase in Generic Competition
8.5.3. Healthcare Budget Restraints
8.6. Porter’s Five Force Analysis
8.6.1. Rivalry Among Competitors [High]
8.6.2. Threat of New Entrants [High]
8.6.3. Power of Suppliers [Low]
8.6.4. Power of Buyers [High]
8.6.5. Threat of Substitutes [Low]
9. Conclusions
9.1. The Prostate Cancer Therapeutics Market, 2016-2026
9.2. The US Will Remain the Largest National Market from 2016 to 2026
9.3. Concluding Remarks
10. Glossary
【レポート販売概要】
■ タイトル：前立腺がん治療の世界市場2016-2026■ 英文：The Prostate Cancer Market 2016-2026
■ 発行日：2016年4月
■ 調査会社：visiongain
■ 商品コード：VGAIN60627
■ 調査対象地域：グローバル
- 世界の運動用フットウェア市場動向（2012-2016）TechNavio's analysts forecast the Global Athletic Footwear market to grow at a CAGR of 1.75 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for comfortable footwear. The Global Athletic Footwear market has also been witnessing the increasing demand for lightweight athletic shoes. However, the increasing availability of counterfe …
- 家電用ジェスチャー認識の世界市場2018-2022About gesture recognition for consumer electronic devices Gesture recognition technology analyses human motions through computer algorithms. This consists of generating gestures and capturing them using a camera. The software identifies the gesture and matches it with the database to perform the necessary action. Technavio’s analysts forecast the Global gesture recognition market for consumer elec …
- LTE・5Gブロードキャストの世界市場展望2017-2026According to Stratistics MRC, the Global LTE and 5G Broadcast Market is accounted for $371.89 million in 2017 and is expected to reach $1,099.50 million by 2026 growing at a CAGR of 12.8% during the forecast period. Factors such as increasing LTE mobile subscribers and penetration of smartphones and need of minimizing network capacity congestion are fuelling the market growth. However, reluctance …
- Range Resources Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Range Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Range Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 携帯端末管理（MDM）：インフラ及びサービス2014-2019（Mobile Device Management (MDM): Infrastructure and Services 2014 – 2019）Mobile Device Management (MDM) represents solutions that secure, monitor, manage and support mobile/wireless devices deployed across mobile network operators (MNO), other service providers and enterprise companies. MDM is a useful tool for a MNO to manage the many different device types across their network. It is also useful for MNO to manage periodically required device updates and administratio …
- 世界のアクティブ光ケーブル市場2015The Global Active Optical Cables Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Active Optical Cables industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Active Optical Cables market analysis is provided for the international markets including deve …
- ストリーミング分析の世界市場：不正利用検知、販売・マーケティング管理、アセットメインテナンス、リスク管理、ネットワーク管理、ロケーションインテリジェンス、運用管理The streaming analytics market size is expected to grow from USD 3.08 Billion in 2016 to USD 13.70 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 34.8% during the forecast period. The major growth drivers of the market include the emergence of Internet of Things (IoT) enabled technologies, increasing focus on competitive insights, increasing business agility and scalability, and incre …
- 世界のデータセンターUPS市場動向（2012-2016）TechNavio's analysts forecast the Global Data Center UPS market to grow at a CAGR of 6.46 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of online services by enterprises. The Global Data Center UPS market has also been witnessing an increased need for uninterrupted data services. However, the slow pace of technological advan …
- 世界の海水淡水化市場：多段フラッシュ方式、多重効用法（MED）、逆浸透法、電気透析法About Water Desalination Water desalination refers to the removal of salt and other minerals from saline water. It is used to address fresh water supplies amidst increasing population, industrialization, and pollution. Desalinated water can be used in water drought-hit areas as alternative water source to increase water production yield. Water scarcity in various parts of the globe has become one …
- NxStage Medical, Inc.：市場シェア分析NxStage Medical, Inc. Market Share Analysis Summary GlobalData’s new report, “NxStage Medical, Inc. Market Share Analysis” provides in-depth information on NxStage Medical, Inc.’s market position in the renal dialysis equipment market. The report also provides data and information on the overall competitive landscape within the renal dialysis equipment market. The report is supplemented with globa …
- シンフィルム(Thin-Film)印刷電池市場2014-2021NanoMarkets has provided coverage on the thin-film and printed batteries market for six years and has a deep understanding of what makes this market tick. During the period we have covered these power sources, some of the firms in this space have made slow but steady progress both technically and in terms of business development; a few of them are generating significant revenue. Other thin-film an …
- Luliconazole (Dermatophytic Onychomycosis)：市場予測と分析（～2022）Luliconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Luliconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022”. Dermatophytic onychomycosis (DO) is characterized as being a fungal infection of the nail. Infection can involve the nail unit (nail matrix, nail bed, or nai …
- グローバルスキンケア製品市場におけるM&A動向（2014年3月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global skincare market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global skincare market throughout the month. Additionally, the report provides an overview of all the partneri …
- 自動車用スチールホイールの世界市場2018-2022About Automotive Steel Wheels Automotive steel wheels are circular shaped rims on which the tires are mounted. They are responsible for enabling mobility of an automobile and to carry the weight of the vehicle. From conventional cast-iron wheels to high-performance carbon fiber alloys, automotive wheels have evolved significantly in terms of the materials used to manufacture them. Technavio’s anal …
- 自動車用ISOFIXマウントの世界市場2019-2023Global Automotive ISOFIX Mounts Market: About this market Technavio’s automotive ISOFIX mounts market analysis considers sales from both OEM and aftermarket. Our analysis also considers the sales of automotive ISOFIX mounts in APAC, Europe, North America, South America, and MEA. In 2018, the OEM segment had a significant market share, and this trend is expected to continue over the forecast period …
